Evidence map›Paper›PMID 41491253›Full record

ArticleNature biotechnology2026

Revealing a coherent cell-state landscape across single-cell datasets with CONCORD.

Qin Zhu, Zuzhi Jiang, Binyamin Zuckerman, Leor Weinberger, Matt Thomson, Zev J Gartner

Abstract read
PubMed Publisher
In one paragraph

Article in Nature biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Arteriosclerosis, thrombosis, and vascular biology · 2026
    Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Qin ZhuDepartment of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA. qin.zhu@ucsf.edu.ORCID http://orcid.org/0000-0001-5539-6071
Zuzhi JiangDepartment of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA.ORCID http://orcid.org/0009-0009-1402-8235
Binyamin ZuckermanDepartment of Cell and Systems Biology, University of Miami, Miami, FL, USA.ORCID http://orcid.org/0000-0002-6216-011X
Leor WeinbergerDepartment of Cell and Systems Biology, University of Miami, Miami, FL, USA.
Matt ThomsonDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA.ORCID http://orcid.org/0000-0003-1021-1234
Zev J GartnerDepartment of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA. zev.gartner@ucsf.edu.ORCID http://orcid.org/0000-0001-7803-1219

Funding

Modulating Stochastic Gene Expression for Cell-fate Control and TherapeuticsR37AI109593 · NIAID · J. DAVID GLADSTONE INSTITUTES · PI WEINBERGER, LEOR S · 2021 to 2025
$6.2M
The physical and molecular mechanisms of intestinal villus morphogenesis and repairR01DK126376 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Zev Jordan Gartner · 2020 to 2026
$4.2M
Integrative approach to heterogeneity in breast cancer metastasisU01CA199315 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GOGA, ANDREI, SPELLMAN, PAUL T. · 2016 to 2020
$3.2M
Universal Sample Multiplexing for Single Cell AnalysisR33CA247744 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GARTNER, ZEV JORDAN · 2021 to 2023
$1.2M
Increasing organoid reproducibility and complexity for drug testing and disease modelingR33CA297969 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Zev Jordan Gartner · 2025 to 2026
$784k
Cancer Research Institute (CRI) CRI5054NCI NIH HHS R33 CA247744NCI NIH HHS R33 CA297969NIDDK NIH HHS R01 DK126376U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) R33CA247744U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) U01CA199315U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R37AI109593U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases) R01DK126376
6 · The paper itself

Abstract

Revealing the underlying cell-state landscape from single-cell data requires overcoming the critical obstacles of batch integration, denoising and dimensionality reduction. Here we present CONCORD, a unified framework that simultaneously addresses these challenges within a single self-supervised model. At its core, CONCORD implements a probabilistic sampling strategy that corrects batch effects through dataset-aware sampling and enhances biological resolution through hard-negative sampling. Using only a minimalist neural network with a single hidden layer and contrastive learning, CONCORD surpasses state-of-the-art performance without relying on deep architectures, auxiliary losses or external supervision. It seamlessly integrates data across batches, technologies and even species to generate high-resolution cell atlases. The resulting latent representations are denoised and biologically meaningful, capturing gene coexpression programs, revealing detailed lineage trajectories and preserving both local geometric relationships and global topological structures. We demonstrate CONCORD's broad applicability across diverse datasets, establishing it as a general-purpose framework for learning unified, high-fidelity representations of cellular identity and dynamics.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.